Beleggen.nl Markt MonitorMarkt Monitor

Corus Terug naar discussie overzicht

Major shareholders per november 2006

3 Posts
| Omlaag ↓
  1. k.bruin 24 november 2006 20:14
    Major shareholders
    At November 2006, Corus Group had been notified of the following substantial shareholdings in its issued ordinary share capital:

    Standard Life Investments 7.81%
    UBS AG 7.36%
    Barclays plc 4.70%
    Goldman Sachs 4.01%
    Legal & General Investment Mgt 3.82%
    Supernova Acquisitions 3.80%
    Lehman Brothers 3.45%
    Capital Group 3.05%

    De posities worden ingenomen in het gevecht rondom Corus. CSN heeft al aardig wat stukken binnengehaald. Nu het officiele bod nog.
  2. [verwijderd] 27 november 2006 10:36
    The Board of Corus has decided that it is in the best interests of Corus
    Shareholders to allow CSN some additional time to satisfy its pre-conditions and
    to determine whether it will put forward a formal offer.

    Dus; Van de drie eisen die CSN heeft is er al 1 voldaan. Men wil namelijk een poitief advies van de raad van bestuur. Dat de board meent dat het in the best interests of corus shareholders is, zegt genoeg op dat punt.

    At this time, the Panel on Takeovers and Mergers (the "Panel") has not set a
    date by which CSN is required to clarify its intentions and either announce a
    formal offer for Corus or confirm its intention not to do so. In the event that
    the Panel subsequently sets such a deadline, an appropriate announcement will be
    made.

    Dus; Het leidende overname team stelt geen momenteel geen harde deadline aan CSN om een bod uit te brengen. Mocht die deadline er komen worden we daarvan op de hoogte gebracht.

    Bron van engelste tekst;
    BETTEN BEURSMEDIA NEWS
  3. k.bruin 6 december 2006 18:12
    Standard Life Investments 7.81%
    UBS AG 7.36%
    Barclays plc 4.70%
    Goldman Sachs 4.01%
    Legal & General Investment Mgt 3.82%
    Supernova Acquisitions 3.80%
    Lehman Brothers 3.45%
    Capital Group 3.05%

    Toegevoegd:

    Melding via regulatory news op 6-12:

    Merrill Lynch 6,13 %

    Totaal 44,13 % bij institutionele beleggers.
3 Posts
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beleggen.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.101
AB InBev 2 5.529
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.890
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.795
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.772
Aedifica 3 925
Aegon 3.258 322.988
AFC Ajax 538 7.088
Affimed NV 2 6.300
ageas 5.844 109.897
Agfa-Gevaert 14 2.061
Ahold 3.538 74.343
Air France - KLM 1.025 35.241
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.046
Alfen 16 25.071
Allfunds Group 4 1.511
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 409
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.579
AMG 971 134.069
AMS 3 73
Amsterdam Commodities 305 6.740
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 15.029
Apollo Alternative Assets 1 17
Apple 5 384
Arcadis 252 8.789
Arcelor Mittal 2.034 320.880
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.342
Aroundtown SA 1 221
Arrowhead Research 5 9.749
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.559
ASML 1.766 109.394
ASR Nederland 21 4.505
ATAI Life Sciences 1 7
Atenor Group 1 522
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.728
Axsome Therapeutics 1 177
Azelis Group 1 66
Azerion 7 3.412